2 months ago
VRTX
AnalystsMichael YeeMichael Yee's Stock Forecasts
AnalystsMichael Yee
Analyst Ranking
Top 15%
#774 out of 5216 analysts
Average Return
+11.09%
Win Rate
48%41 out of 86
Risk vs Reward
Poor
Good
Michael Yee's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Beam Therapeutics IncBEAM | +300.96% | $23.02 | $92.30 | 2020-03-02 - 2021-03-02 | Strong Buy |
Scholar Rock Holding CorpSRRK | +221.62% | $9.02 | $29.01 | 2023-10-25 - 2024-10-24 | Strong Buy |
Rayzebio IncRYZB | +212.45% | $20.00 | $62.49 | 2023-10-10 - 2024-02-23 | Strong Buy |
Denali Therapeutics IncDNLI | +194.23% | $22.69 | $66.76 | 2020-02-24 - 2021-02-24 | Strong Buy |
Kodiak Sciences IncKOD | +157.54% | $10.15 | $26.14 | 2024-12-09 - 2025-12-08 | Strong Buy |
Michael Yee Analyst Color
Get additional color on Michael Yee's coverage of popular stocks
2 months ago
GILD
2 months ago
IMCR
2 months ago
IVA
2 months ago
ANAB
2 months ago
BMY
2 months ago
GILD
2 months ago
LLY
a year ago
ALXO
a year ago
DNLI
2 years ago
NUVB
2 years ago
ALXO
3 years ago
ALGS
3 years ago
MRNA
3 years ago
BIIB
3 years ago
BIIB
Michael Yee's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Nuvation Bio IncNUVB | 5 | Hold | $7.00 | +60.18% | Maintains | 10 days ago |
Arcellx IncACLX | 2 | Hold | $115.00 | +0.62% | Downgrades | 17 days ago |
Galecto IncGLTO | 1 | Strong Buy | $45.00 | +70.65% | Initiates Coverage On | 24 days ago |
Abbvie IncABBV | 2 | Hold | $230.00 | +2.05% | Maintains | a month ago |
Vertex Pharmaceuticals IncVRTX | 5 | Strong Buy | $545.00 | +13.99% | Maintains | 2 months ago |
Gilead Sciences IncGILD | 4 | Strong Buy | $155.00 | +6.74% | Maintains | 2 months ago |
Amgen IncAMGN | 7 | Strong Buy | $390.00 | +6.04% | Maintains | 2 months ago |
Ventyx Biosciences IncVTYX | 3 | Hold | $14.00 | 0.00% | Downgrades | 2 months ago |
Ideaya Biosciences IncIDYA | 1 | Strong Buy | $50.00 | +52.30% | Assumes | 2 months ago |
Denali Therapeutics IncDNLI | 3 | Strong Buy | $25.00 | +20.77% | Assumes | 2 months ago |
Immunocore Holdings PLCIMCR | 2 | Strong Buy | $55.00 | +77.19% | Assumes | 2 months ago |
Inventiva SaIVA | 1 | Strong Buy | $12.00 | +94.49% | Assumes | 2 months ago |
Anaptysbio IncANAB | 1 | Strong Buy | $70.00 | +9.74% | Assumes | 2 months ago |
Viridian Therapeutics IncVRDN | 1 | Strong Buy | $50.00 | +75.99% | Initiates Coverage On | 2 months ago |
Scholar Rock Holding CorpSRRK | 3 | Strong Buy | $60.00 | +43.54% | Initiates Coverage On | 2 months ago |
Schrodinger IncSDGR | 2 | Hold | $18.00 | +48.03% | Initiates Coverage On | 2 months ago |
Sab Biotherapeutics IncSABS | 1 | Strong Buy | $7.00 | +52.51% | Initiates Coverage On | 2 months ago |
Oruka Therapeutics IncORKA | 2 | Strong Buy | $50.00 | +56.30% | Initiates Coverage On | 2 months ago |
Olema Pharmaceuticals IncOLMA | 1 | Strong Buy | $45.00 | +201.81% | Initiates Coverage On | 2 months ago |
Mbx Biosciences IncMBX | 2 | Strong Buy | $60.00 | +114.67% | Initiates Coverage On | 2 months ago |
Kodiak Sciences IncKOD | 4 | Strong Buy | $50.00 | +110.17% | Initiates Coverage On | 2 months ago |
Beam Therapeutics IncBEAM | 3 | Hold | $28.00 | +9.42% | Initiates Coverage On | 2 months ago |
Allogene Therapeutics IncALLO | 1 | Strong Buy | $8.00 | +223.89% | Initiates Coverage On | 2 months ago |
Zai Lab LtdZLAB | 1 | Strong Buy | $35.00 | +85.48% | Initiates Coverage On | 2 months ago |
Aligos Therapeutics IncALGS | 2 | Strong Buy | $20.00 | +169.91% | Initiates Coverage On | 2 months ago |
Bristol Myers Squibb CoBMY | 1 | Strong Buy | $65.00 | +10.26% | Upgrades | 2 months ago |
Biogen IncBIIB | 6 | Hold | $185.00 | +0.05% | Assumes | 2 months ago |
Pfizer IncPFE | 1 | Hold | $25.00 | -6.92% | Assumes | 2 months ago |
Eli Lilly & CoLLY | 1 | Strong Buy | $1,250.00 | +27.91% | Assumes | 2 months ago |
Cargo Therapeutics IncCRGX | 4 | Hold | $5.00 | +11.86% | Maintains | 8 months ago |
Blueprint Medicines CorpBPMC | 1 | Strong Buy | $135.00 | +4.28% | Initiates Coverage On | a year ago |
Alx Oncology Holdings IncALXO | 4 | Strong Buy | $3.00 | N/A | Upgrades | a year ago |
Moderna IncMRNA | 8 | Hold | $55.00 | N/A | Maintains | a year ago |
Axon Enterprise IncAXON | 3 | Strong Buy | $385.00 | N/A | Initiates Coverage On | 2 years ago |
Immuneering CorpIMRX | 2 | Hold | $3.00 | N/A | Downgrades | 2 years ago |
LianbioLIANY | 2 | Hold | $4.00 | N/A | Downgrades | 2 years ago |
Cerevel Therapeutics Holdings IncCERE | 1 | Hold | $45.00 | N/A | Downgrades | 2 years ago |
Amarin Corp PLCAMRN | 8 | Hold | $20.00 | N/A | Downgrades | 2 years ago |
Rayzebio IncRYZB | 1 | Strong Buy | $35.00 | N/A | Initiates Coverage On | 2 years ago |
Prometheus Biosciences IncRXDX | 1 | Hold | $200.00 | N/A | Downgrades | 3 years ago |
Invivyd IncIVVD | 1 | Strong Buy | $60.00 | N/A | Initiates Coverage On | 5 years ago |
Kyntra Bio IncKYNB | 2 | Hold | $1,125.00 | N/A | Downgrades | 5 years ago |
Esperion Therapeutics IncESPR | 3 | Hold | $30.00 | N/A | Downgrades | 5 years ago |
Prothena Corp Public Ltd CoPRTA | 3 | Strong Buy | $30.00 | N/A | Upgrades | 5 years ago |
Assembly Biosciences IncASMB | 2 | Hold | $120.00 | N/A | Downgrades | 5 years ago |
Inhibrx IncINBX1 | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 5 years ago |
Urogen Pharma LtdURGN | 2 | Strong Buy | $77.00 | N/A | Assumes | 7 years ago |
Immunomedics IncIMMU | 2 | Strong Buy | $30.00 | N/A | Assumes | 7 years ago |
Odonate Therapeutics IncODTC | 1 | Strong Buy | $40.00 | N/A | Initiates Coverage On | 8 years ago |
Acorda Therapeutics IncACORQ | 2 | Hold | $3,000.00 | N/A | Maintains | 8 years ago |
Spectrum Pharmaceuticals IncSPPI | 1 | Strong Buy | $18.00 | N/A | Maintains | 8 years ago |
Intercept Pharmaceuticals IncICPT | 1 | Strong Buy | $275.00 | N/A | Initiates Coverage On | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.